Alon Skaat1, Carlos Gustavo De Moraes2, Christopher Bowd3, Pamela A Sample3, Christopher A Girkin4, Felipe A Medeiros3, Robert Ritch5, Robert N Weinreb3, Linda M Zangwill3, Jeffrey M Liebmann6. 1. New York Eye and Ear Infirmary, New York, New York; Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 2. Bernard and Shirlee Brown Glaucoma Research Laboratory, Harkness Eye Institute, Columbia University Medical Center, New York, New York. Electronic address: gustavo.demoraes@columbia.edu. 3. Hamilton Glaucoma Center, Department of Ophthalmology, University of California, San Diego, California. 4. School of Medicine, University of Alabama, Birmingham, Alabama. 5. New York Eye and Ear Infirmary, New York, New York. 6. Bernard and Shirlee Brown Glaucoma Research Laboratory, Harkness Eye Institute, Columbia University Medical Center, New York, New York.
Abstract
PURPOSE: To investigate the differences in the frequency of optic disc hemorrhage (DH) and prevalence of beta-zone parapapillary atrophy (βPPA) between individuals of African descent (AD) and European descent (ED). DESIGN: Prospective, multicenter, observational cohort. PARTICIPANTS: A total of 1950 eyes of 1172 participants of the African Descent and Glaucoma Evaluation Study (ADAGES). METHODS: Stereoscopic disc photographs of subjects with and without glaucomatous optic neuropathy (GON) followed during the first 13 years of the ADAGES underwent masked review searching for DH and βPPA. A total of 928 eyes (non-GON, 581; GON, 347) of 551 AD patients (non-GON, 334; GON, 217) and 1022 eyes (non-GON, 568; GON, 454) of 611 ED patients (non-GON, 334; GON, 277) were included. We compared the number of eyes with detected DH at any time during follow-up and eyes with βPPA between the AD and ED groups. The analyses were then adjusted for clinical parameters using multivariable logistic regression. MAIN OUTCOME MEASURES: Differences in frequency of DH and prevalence of βPPA. RESULTS: A total of 9395 stereoscopic disc photographs were reviewed. More ED eyes experience DH than AD eyes (49/1022 [4.8%] vs. 10/928 eyes [1.1%], respectively; P < 0.001), whereas βPPA had higher prevalence in AD eyes (675 eyes [72%] vs. 659 eyes [64%]; P < 0.001). In the final multivariable model, after controlling for confounders, AD eyes were less likely to have at least 1 detected DH than ED eyes (odds ratio [OR], 0.21; 95% CI, 0.10-0.45; P < 0.001) but were more likely to have βPPA than ED eyes (OR, 1.55; 95% CI, 1.12-2.14; P = 0.008). CONCLUSIONS: Subjects of ED are at higher risk for developing DH compared with AD subjects, whereas AD subjects have greater prevalence of βPPA. These findings suggest that there are structural differences within the optic nerve complex between these groups. Further research is needed to determine whether racial differences in the frequency of DH and prevalence of βPPA affect the likelihood of glaucomatous progression.
PURPOSE: To investigate the differences in the frequency of optic disc hemorrhage (DH) and prevalence of beta-zone parapapillary atrophy (βPPA) between individuals of African descent (AD) and European descent (ED). DESIGN: Prospective, multicenter, observational cohort. PARTICIPANTS: A total of 1950 eyes of 1172 participants of the African Descent and Glaucoma Evaluation Study (ADAGES). METHODS: Stereoscopic disc photographs of subjects with and without glaucomatous optic neuropathy (GON) followed during the first 13 years of the ADAGES underwent masked review searching for DH and βPPA. A total of 928 eyes (non-GON, 581; GON, 347) of 551 ADpatients (non-GON, 334; GON, 217) and 1022 eyes (non-GON, 568; GON, 454) of 611 ED patients (non-GON, 334; GON, 277) were included. We compared the number of eyes with detected DH at any time during follow-up and eyes with βPPA between the AD and ED groups. The analyses were then adjusted for clinical parameters using multivariable logistic regression. MAIN OUTCOME MEASURES: Differences in frequency of DH and prevalence of βPPA. RESULTS: A total of 9395 stereoscopic disc photographs were reviewed. More ED eyes experience DH than AD eyes (49/1022 [4.8%] vs. 10/928 eyes [1.1%], respectively; P < 0.001), whereas βPPA had higher prevalence in AD eyes (675 eyes [72%] vs. 659 eyes [64%]; P < 0.001). In the final multivariable model, after controlling for confounders, AD eyes were less likely to have at least 1 detected DH than ED eyes (odds ratio [OR], 0.21; 95% CI, 0.10-0.45; P < 0.001) but were more likely to have βPPA than ED eyes (OR, 1.55; 95% CI, 1.12-2.14; P = 0.008). CONCLUSIONS: Subjects of ED are at higher risk for developing DH compared with AD subjects, whereas AD subjects have greater prevalence of βPPA. These findings suggest that there are structural differences within the optic nerve complex between these groups. Further research is needed to determine whether racial differences in the frequency of DH and prevalence of βPPA affect the likelihood of glaucomatous progression.
Authors: Maziar Lalezary; Felipe A Medeiros; Robert N Weinreb; Christopher Bowd; Pamela A Sample; Ivan M Tavares; Ali Tafreshi; Linda M Zangwill Journal: Am J Ophthalmol Date: 2006-10 Impact factor: 5.258
Authors: Christopher C Teng; Carlos Gustavo V De Moraes; Tiago S Prata; Celso Tello; Robert Ritch; Jeffrey M Liebmann Journal: Ophthalmology Date: 2010-02-04 Impact factor: 12.079
Authors: Felipe A Medeiros; Pamela A Sample; Linda M Zangwill; Christopher Bowd; Makoto Aihara; Robert N Weinreb Journal: Am J Ophthalmol Date: 2003-11 Impact factor: 5.258
Authors: C Gustavo De Moraes; James T Murphy; Chad M Kaplan; Jeremy J Reimann; Alon Skaat; Dana M Blumberg; Lama Al-Aswad; George A Cioffi; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda Zangwill; Jeffrey M Liebmann Journal: JAMA Ophthalmol Date: 2017-06-01 Impact factor: 7.389
Authors: Xiongfei Liu; Alicia Lau; Huiyuan Hou; Sasan Moghimi; James A Proudfoot; Eric Chan; Jiun Do; Andrew Camp; Derek Welsbie; Carlos Gustavo de Moraes; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Ophthalmol Glaucoma Date: 2021-01-30
Authors: Andrew J Nelson; Ryuna Chang; Vivian LeTran; Brian Vu; Bruce Burkemper; Zhongdi Chu; Ali Fard; Amir Kashani; Benjamin Xu; Ruikang Wang; Rohit Varma; Grace M Richter Journal: Invest Ophthalmol Vis Sci Date: 2019-08-01 Impact factor: 4.799
Authors: Sasan Moghimi; Linda M Zangwill; Huiyuan Hou; Brandon Wong; James Proudfoot; Rafaella C Penteado; Eren Ekici; Christopher Bowd; Robert N Weinreb Journal: Ophthalmol Glaucoma Date: 2020-07-18
Authors: Eren Ekici; Sasan Moghimi; Huiyuan Hou; James Proudfoot; Linda M Zangwill; Jiun L Do; Won Hyuk Oh; Alireza Kamalipour; Jeffrey M Liebmann; Carlos Gustavo De Moraes; Christopher A Girkin; Nevin El-Nimri; Robert N Weinreb Journal: Am J Ophthalmol Date: 2020-10-29 Impact factor: 5.258
Authors: Ryan Caezar C David; Sasan Moghimi; Jiun L Do; Huiyuan Hou; James Proudfoot; Linda M Zangwill; Alireza Kamalipour; Takashi Nishida; Carlos Gustavo De Moraes; Christopher A Girkin; Jeffrey M Liebmann; Robert N Weinreb Journal: Am J Ophthalmol Date: 2021-06-06 Impact factor: 5.488
Authors: Clara C Cousins; Billy X Pan; Jonathan C Chou; Lucy Q Shen; Mae O Gordon; Michael A Kass; Robert Ritch; Louis R Pasquale Journal: Am J Ophthalmol Date: 2020-04-23 Impact factor: 5.488